A randomized comparison of once- versus twice-daily Mmx® mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis

被引：0
|
作者：
Kamm, Michael A.
Colombel, Jean-frederic
Kornbluth, Asher
Diebold, Ron
Barrett, Karen
Karlstadt, Robyn G.
Joseph, Raymond E.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A510 / A510
页数：1
相关论文
共 50 条
  • [1] Once- or twice-daily MMX™ mesalamine for the maintenance of remission of mild or moderate ulcerative colitis
    Panaccione, Remo
    Kamm, Michael A.
    Karlstadt, Robyn
    Diebold, Ron
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S463 - S463
  • [2] Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Schreiber, S.
    Lees, K.
    Barrett, K.
    Joseph, R.
    GUT, 2008, 57 (07) : 893 - 902
  • [3] MMX™ mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis
    Sandborn, W.
    Kamm, M.
    Lichtenstein, G.
    Barrett, K.
    Joseph, R.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [4] Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Boddu, Prabhakar
    Gubergrits, Natalya
    Lyne, Andrew
    Butler, Todd
    Lees, Kirstin
    Joseph, Raymond E.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 95 - 102
  • [5] Patients with quiescent mild-to-moderate ulcerative colitis receiving a multiple-daily dose 5-aminosalicylic acid formulation can maintain remission with once- or twice-daily Mmx® mesalamine
    Lichtenstein, Gary R.
    Diebold, Ron
    Karlstadt, Robyn G.
    Barrett, Karen
    Joseph, Raymond E.
    GASTROENTEROLOGY, 2007, 132 (04) : A510 - A510
  • [6] Once-versus twice-daily MMX® mesalazine for the maintenance of remission in mild-to-moderate ulcerative colitis: a 12-month, phase III, randomised study
    Kamm, Michael
    Colombel, Jean-Frederic
    Kornbluth, Asher
    Karlstadt, Robyn
    Solomon, Dory
    Abhyankar, Brihad
    Barrett, Karen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 81 - 81
  • [7] Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
    D'Haens, Geert
    Sandborn, William J.
    Barrett, Karen
    Hodgson, Ian
    Streck, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07): : 1064 - 1077
  • [8] Satisfaction with therapy among patients treated with MMX™ mesalamine for maintenance of remission in patients with mild-to-moderate ulcerative colitis
    Sandborn, W.
    Lichtenstein, G.
    Kamm, M.
    Barrett, K.
    Joseph, R.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [9] MMX™ mesalamine is effective for the maintenance of remission of mild-to-moderate ulcerative colitis irrespective of patients' previous relapse history
    Sandborn, William J.
    Karlstadt, Robyn
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S461 - S462
  • [10] Once-daily 1.5-g granulated mesalamine is effective and safe in maintenance of remission in mild-to-moderate ulcerative colitis
    Gordon, Glenn
    Pruitt, Ronald
    Ringold, Mark
    Sedghi, Shahriar
    Merchant, Kunal
    Shaw, Audrey
    Yuan, James
    Bortey, Enoch
    Forbes, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S440 - S441
12345